The measure of circulating hormones that are unbound by carrier proteins and thus capable of interacting with target cell receptors to elicit a physiological response. This measurement moves beyond total hormone assays to reflect the actual functional level available for cellular signaling. Accurate assessment is critical for understanding true endocrine availability within human physiology.
Origin
This concept originates from a deeper understanding of endocrinology where the importance of free fractions of steroid and thyroid hormones became clinically evident. It evolved from recognizing that protein binding significantly modulates hormone action. The term highlights the functional component over mere concentration.
Mechanism
The status is determined by quantifying free or weakly bound hormones, often through equilibrium dialysis or highly sensitive immunoassays that account for Sex Hormone Binding Globulin (SHBG) and other transport proteins. Low bioactive levels indicate reduced receptor engagement despite potentially normal total hormone levels. This pathway dictates the magnitude of downstream genomic and non-genomic effects of endocrine signals.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.